IO Biotech to Participate in Panel Discussion at 30th Annual Cancer Progress Conference in New York

Wednesday, May 1, 2019 General News
Email Print This Page Comment bookmark
Font : A-A+

COPENHAGEN, Denmark, May 1, 2019 /PRNewswire/ -- IO Biotech's CEO, Mai-Britt Zocca, Ph.D., will participate in a panel discussion entitled, "IO Session I: Combination Failures & Futures: Much Ado About What?" at the 30th Annual Cancer Progress Conference in New York City on May

7-8, 2019. 

IO Biotech will participate in the discussion together with senior executives from GlaxoSmithKline, Cancer Research Institute, Parker Institute For Cancer Immunotherapy, Agenus, and KAPital Consulting. The discussion will be moderated by Jeffrey M. Bockman, PhD, Executive Vice President, Head of Oncology Practice, Cello Health BioConsulting.

The discussion is to take place on Tuesday, May 7, 2019 from 3:15 to 4:30 PM at Convene at 32 Old Slip, New York. More information is available at www.cancerprogressbydh.com.

About T-winŽ Technology Platform IO Biotech's proprietary T-win technology platform enables identification of compounds with dual mechanism of action targeting and directly killing immunosuppressive cells and tumor cells while indirectly activating other T-effectors, leading to strong anti-tumor responses. 

About IO Biotech IO Biotech is a clinical stage biotech company developing disruptive immune therapies for the treatment of cancer. The pipeline of first-in-class immune modulating anti-cancer therapies is developed by a unique technology platform, T-WinŽ, enabling the activation of T cells that are specific for immune-suppressive molecules. IO Biotech has a proven track record of progressing preclinical and clinical compounds. The two lead compounds targeting IDO and PD-L1 are in clinical development and several pipeline compounds are in pre-clinical phase. For further information, please visit www.iobiotech.com.

ContactsMai-Britt Zocca, PhD, CEO and founder of IO BiotechE-mail: mz@iobiotech.com

 

Cision View original content:http://www.prnewswire.com/news-releases/io-biotech-to-participate-in-panel-discussion-at-30th-annual-cancer-progress-conference-in-new-york-300841516.html

SOURCE IO Biotech



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store